Trends and Correlates of HIV Testing During Pregnancy in Racially/Ethnically Diverse Insured Population, 1997–2006
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Objectives To describe the trends in human immunodeficiency virus (HIV) testing during pregnancy from 1997 through 2006, and the demographic, clinical, and health system correlates of being tested in a diverse insured population. Methods Health plan members who had one or more births at ≥20 weeks gestation from January 1, 1997 through December 31, 2006 in Kaiser Permanente Southern California hospitals were included in this retrospective analysis. Data were obtained from the infants’ birth certificate, and administrative and laboratory databases. Multiple log binomial regression analyses were used to generate adjusted prevalence ratios (PR) and 95% confidence interval (CI) for each characteristic. Results Of the 240,575 women with 302,246 pregnancies, the proportion tested for HIV during pregnancy increased from 77.6% in 1997 to 91.0% in 2006 (P trend < 0.0001). Compared with Hispanic women, of which 90% were tested, non-Hispanic white women were least likely to be tested (81.7%: PR: 0.965; 95% CI: 0.957–0.973). Demographic characteristics negatively associated with HIV testing were maternal age ≥30, having more than a high school education, and residing in census blocks with the highest income tertile. Additionally, women were less likely to be tested after their first birth, if enrolling in prenatal care in the third trimester, or if they had a gap in insurance during their pregnancy. Of the 53,566 women with two sequential pregnancies, 78.5% were tested during both pregnancies. Conclusion In an insured racially/ethnically patient population, the testing rate exceeded 90% in 2006. Achieving and sustaining these high testing levels has public health implications.
- Centers for Disease Control and Prevention. (1995). U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR. Recommendations and Reports, 44(RR-7), 1–15.
- Lansky, A., Jones, J. L., Frey, R. L., & Lindegren, M. L. (2001). Trends in HIV testing among pregnant women: United States, 1994–1999. American Journal of Public Health, 91(8), 1291–1293. CrossRef
- Lansky, A., Sansom, S. L., Harrison, L. L., & Stancil, T. (2007). Trends in prenatal discussion and HIV testing, 1996–2001: Pregnancy Risk Assessment Monitoring System. Maternal and Child Health Journal, 11(6), 526–531. doi:10.1007/s10995-007-0197-0. CrossRef
- Anderson, J. E., & Sansom, S. (2006). HIV testing among U.S. women during prenatal care: findings from the 2002 National Survey of Family Growth. Maternal and Child Health Journal, 10(5), 413–417. doi:10.1007/s10995-006-0120-0. CrossRef
- Tao, G., Patterson, E., Lee, L. M., Sansom, S., Teran, S., & Irwin, K. L. (2005). Estimating prenatal syphilis and HIV screening rates for commercially insured women. American Journal of Preventive Medicine, 28(2), 175–181. doi:10.1016/j.amepre.2004.09.001. CrossRef
- California Health Interview Survey. (2008). Retrieved March 26, 2008 from http://www.chis.ucla.edu.
- Barros, A. J., & Hirakata, V. N. (2003). Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Medical Research Methodology, 3, 21. doi:10.1186/1471-2288-3-21. CrossRef
- Skov, T., Deddens, J., Petersen, M. R., & Endahl, L. (1998). Prevalence proportion ratios: estimation and hypothesis testing. International Journal of Epidemiology, 27(1), 91–95. doi:10.1093/ije/27.1.91. CrossRef
- Centers for Disease Control and Prevention. (1999). Prenatal discussion of HIV testing and maternal HIV testing—14 states, 1996–1997. MMWR. Morbidity and Mortality Weekly Report, 48(19), 401–404.
- Centers for Disease Control and Prevention. (2002). HIV testing among pregnant women—United States and Canada, 1998–2001. MMWR. Morbidity and Mortality Weekly Report, 51(45), 1013–1016.
- Ethier, K. A., Fox-Tierney, R., Nicholas, W. C., Salisbury, K. M., & Ickovics, J. R. (2000). Organizational predictors of prenatal HIV counseling and testing. American Journal of Public Health, 90(9), 1448–1451. CrossRef
- Joo, E., Carmack, A., Garcia-Bunuel, E., & Kelly, C. J. (2000). Implementation of guidelines for HIV counseling and voluntary HIV testing of pregnant women. American Journal of Public Health, 90(2), 273–276. CrossRef
- Sheikh, L. A., Sarnquist, C., Grieb, E. M., Sullivan, B., & Maldonado, Y. A. (2008). Prenatal screening for infectious diseases: An analysis of disparities and adherence to policy in California. Maternal and Child Health Journal. doi: 10.1007/s10995-008-0341-5.
- Yudin, M. H., Barbara, A. M., Guenter, D., Shaul, R. Z., Remis, R. S., & King, S. M. (2006). Medical records and women’s self-report are not reliable sources for determining whether prenatal HIV testing was done. Journal of Obstetrics and Gynaecology Canada, 28(10), 867–872.
- Branson, B. M., Handsfield, H. H., Lampe, M. A., Janssen, R. S., Taylor, A. W., Lyss, S. B., et al. (2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and Reports, 55(RR-14), 1–17.
- Trends and Correlates of HIV Testing During Pregnancy in Racially/Ethnically Diverse Insured Population, 1997–2006
Maternal and Child Health Journal
Volume 13, Issue 5 , pp 633-640
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- HIV infections
- HIV testing
- Prenatal care
- Mass screening
- Industry Sectors
- Author Affiliations
- 1. Research & Evaluation, Kaiser Permanente Southern California, 100 S. Los Robles, 2nd floor, Pasadena, CA, 91101, USA
- 2. Internal Medicine, Los Angeles Medical Center, Kaiser Permanente Southern California, Los Angeles, CA, USA